May 21, 2026
May 21, 2026
May 21, 2026
May 21, 2026
May 21, 2026
May 21, 2026
May 21, 2026
May 21, 2026
RTW Investments just acquired over 7.6 million shares in Apellis Pharmaceuticals, marking a substantial $192.59 million stake. But what's driving this investment, and how could it affect the biotech market?